<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured circulating C1q-binding adiponectin (C1q-APN) levels before and after 3-month treatment with <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> in people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The results indicate 3-month treatment with <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> reduces circulating levels of C1q-APN/total-adiponectin ratio without changes in body mass index </plain></SENT>
</text></document>